Vigil Neuroscience, Inc. Asset Profile

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

Year established

2020

Location

Watertown MA US

Primary Industry

Biotechnology

About

Founded in 2020 and based in Massachusetts, US, Vigil Neuroscience, Inc., a.k.a. Vigil Neuro develops microglia-based therapies for the treatment of neurodegenerative diseases. In August 2021, Vigil Neuroscience, Inc. raised USD 90 million in a Series B funding led by Vida Ventures, with participation from Cormorant Asset Management, LLC, Deep Track Capital, Invus, Lightstone Ventures, Logos Capital Partners, OrbiMed Advisors, Pivotal bioVenture Partners, Rock Springs Capital, Surveyor Capital, Atlas Venture, Hatteras Venture Partners, and Northpond Ventures. As of November 2021, Vigil Neuroscience, Inc. has raised a total of USD 120 million in funding and Dr. Ivana Magovcevic-Liebisch is President and CEO of the company. Vigil Neuroscience, Inc. develops VGL101, a fully human monoclonal antibody, and small molecule agonists of triggering receptor on myeloid cells 2 (TREM2), which is a microglia sensor that mediates responses to environmental signals to maintain brain homeostasis. Vigil Neuroscience, Inc. plans to use its proceeds from a Series B funding to progress a monoclonal antibody TREM2 agonist, through phase 1 studies, advance its small molecule TREM2 agonist to IND, as well as pursue additional assets to grow the pipeline and increase the body of data supporting microglia biology as an important therapeutic pathway.

Current Investors

Atlas Venture, Alexandria Venture Investments, Hatteras Venture Partners

Request a demo to show more

Primary Industry

Biotechnology

Sub Industries

Molecular Science, Genetics & Gene Therapy, Biopharmaceuticals, Pharmaceutical Research & Development

Website

www.vigilneuro.com

Company Stage

Mature

Total Amount Raised

Subscriber access only

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.